Medifast, Inc. (MED)
NYSE: MED · Real-Time Price · USD
12.22
+0.06 (0.49%)
Aug 26, 2026, 4:00 PM EDT - Market closed
Medifast Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 316.93 | 385.79 | 602.46 | 1,072 | 1,599 | 1,526 | |
Revenue Growth | -34.03% | -35.97% | -43.80% | -32.94% | 4.75% | 63.24% |
Cost of Revenue | 97.48 | 110.6 | 157.84 | 296.2 | 458.16 | 398.49 |
Gross Profit | 219.45 | 275.19 | 444.62 | 775.85 | 1,140 | 1,128 |
Selling, General & Admin | 234.66 | 285.1 | 424.64 | 644.85 | 951.11 | 906.96 |
Research & Development | 4.3 | 4.3 | 4.6 | 4.6 | 4.5 | 4.4 |
Operating Expenses | 238.96 | 289.4 | 429.24 | 649.45 | 955.61 | 911.36 |
Operating Income | -19.51 | -14.21 | 15.38 | 126.4 | 184.81 | 216.24 |
Interest Expense | - | - | - | - | -0.7 | -0.23 |
Interest & Investment Income | 5.57 | 5.52 | 4.8 | 2.49 | - | - |
Other Non Operating Income (Expenses) | -0.04 | 3.06 | -3.9 | -0.1 | -0.05 | 0.12 |
EBT Excluding Unusual Items | -13.97 | -5.64 | 16.29 | 128.8 | 184.06 | 216.13 |
Merger & Restructuring Charges | - | - | -12.5 | - | - | - |
Pretax Income | -13.97 | -5.64 | 3.79 | 128.8 | 184.06 | 216.13 |
Income Tax Expense | 11.63 | 13.03 | 1.7 | 29.38 | 40.49 | 52.1 |
Earnings From Continuing Operations | -25.6 | -18.67 | 2.09 | 99.42 | 143.57 | 164.03 |
Net Income | -25.6 | -18.67 | 2.09 | 99.42 | 143.57 | 164.03 |
Net Income to Common | -25.6 | -18.67 | 2.09 | 99.42 | 143.57 | 164.03 |
Net Income Growth | - | - | -97.90% | -30.75% | -12.47% | 59.47% |
Shares Outstanding (Basic) | 11 | 11 | 11 | 11 | 11 | 12 |
Shares Outstanding (Diluted) | 11 | 11 | 11 | 11 | 11 | 12 |
Shares Change | 0.27% | 0.16% | 0.39% | -3.15% | -4.55% | -0.31% |
EPS (Basic) | -2.32 | -1.70 | 0.19 | 9.13 | 12.82 | 14.01 |
EPS (Diluted) | -2.32 | -1.70 | 0.19 | 9.10 | 12.73 | 13.89 |
EPS Growth | - | - | -97.91% | -28.52% | -8.35% | 60.02% |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | 4.01 | 1.25 | 17.02 | 141.17 | 177.89 | 60.34 |
Free Cash Flow Per Share | 0.36 | 0.11 | 1.55 | 12.93 | 15.78 | 5.11 |
Dividend Per Share | - | - | - | 4.950 | 6.560 | 5.680 |
Dividend Growth | - | - | - | -24.54% | 15.49% | 25.66% |
Gross Margin | 69.24% | 71.33% | 73.80% | 72.37% | 71.34% | 73.89% |
Operating Margin | -6.16% | -3.68% | 2.55% | 11.79% | 11.56% | 14.17% |
Profit Margin | -8.08% | -4.84% | 0.35% | 9.27% | 8.98% | 10.75% |
Free Cash Flow Margin | 1.27% | 0.32% | 2.83% | 13.17% | 11.13% | 3.95% |
EBITDA | -5.66 | 0.03 | 28.09 | 139.51 | 195.79 | 223.05 |
EBITDA Margin | -1.79% | 0.01% | 4.66% | 13.01% | 12.25% | 14.62% |
D&A For EBITDA | 13.85 | 14.24 | 12.71 | 13.11 | 10.98 | 6.81 |
EBIT | -19.51 | -14.21 | 15.38 | 126.4 | 184.81 | 216.24 |
EBIT Margin | -6.16% | -3.68% | 2.55% | 11.79% | 11.56% | 14.17% |
Effective Tax Rate | - | - | 44.79% | 22.81% | 22.00% | 24.10% |
Advertising Expenses | - | 7.5 | 14.1 | 3.4 | 1.7 | 1.6 |